Avestar Capital, LLC Moderna, Inc. Transaction History

Avestar Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$101.21 - $166.61 $61,535 - $101,298	608 Added 32.22%	2,495 $296,000
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $161,093 - $217,835	1,887 New	1,887 $201,000
Q2 2022 Jul 28, 2022	SELL	$117.13 - $176.59 $600,994 - $906,083	-5,131 Reduced 94.35%	307 $44,000
Q4 2021 Feb 01, 2022	SELL	$225.82 - $368.51 $190,592 - $311,022	-844 Reduced 13.44%	5,438 $1.38 Million
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $759,119 - $1.66 Million	-3,421 Reduced 35.26%	6,282 $2.42 Million
Q2 2021 Aug 03, 2021	BUY	$129.91 - $234.98 $23,903 - $43,236	184 Added 1.93%	9,703 $2.28 Million
Q1 2021 May 03, 2021	BUY	$109.18 - $185.98 $135,164 - $230,243	1,238 Added 14.95%	9,519 $1.7 Million
Q4 2020 Feb 01, 2021	BUY	$65.74 - $169.86 $219,571 - $567,332	3,340 Added 67.6%	8,281 $865,000
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $268,493 - $468,653	4,941 New	4,941 $347,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.